MDRX OTC
Veradigm Inc.
1W: +0.0%
1M: -5.9%
3M: -5.0%
YTD: +4.4%
1Y: +0.0%
3Y: -64.5%
5Y: -66.5%
$4.75
+0.00 (+0.00%)
Weekly Expected Move ±3.9%
$5
$5
$5
$5
$5
Credit Risk of going bust: not rated Debt: 21.3% of company value Bonds: none of note held by US funds details ▾
Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (24h)
1
Hourly Sentiment (24h)
-0.90
Bearish
0 bullish
0 neutral
1 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (10)
Veradigm (NASDAQ:MDRX) Share Price Crosses Below 200 Day Moving Average – Here’s Why
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Aug 2026
Veradigm (NASDAQ:MDRX) Trading 14.9% Higher – What’s Next?
Veradigm avoids enforcement action following SEC investigation
Veradigm Provides Business and Strategy Update
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
Veradigm to Release Business Update February 17th and Host Investor Call February 18th
Veradigm Extends Stockholder Rights Plan
Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices
Veradigm (NASDAQ:MDRX) Shares Gap Up – What’s Next?